Stephen Mullennix
2020
Compensation breakdown
| Non-Equity Incentive Plan | $140,200 |
|---|---|
| Option Awards | $292,055 |
| Salary | $139,311 |
| Stock Awards | $88,230 |
| Other | $246,581 |
| Total | $906,376 |
Mullennix received $292.1K in option awards, accounting for 32% of the total pay in 2020.
Mullennix also received $140.2K in non-equity incentive plan, $139.3K in salary, $88.2K in stock awards and $246.6K in other compensation.
Rankings
In 2020, Stephen Mullennix's compensation ranked 9,031st out of 13,090 executives tracked by ExecPay. In other words, Mullennix earned more than 31.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,031 out of 13,090 | 31st |
Division Manufacturing | 3,857 out of 5,621 | 31st |
Major group Chemicals And Allied Products | 1,561 out of 2,254 | 31st |
Industry group Drugs | 1,364 out of 1,954 | 30th |
Industry Pharmaceutical Preparations | 1,009 out of 1,459 | 31st |
Pay ratio
| Stephen Mullennix's Pay | $906,376 |
|---|---|
| Median Employee's Pay | $222,109 |
| Pay Ratio | 4to 1 |
In 2020, the annual total compensation of Stephen Mullennix was $906,376.
The annual total compensation of the median employee at UroGen Pharma Ltd. was $222,109.
The ratio of Stephen Mullennix's pay to the pay of median employee was therefore 4 to one.
Mullennix's colleagues
We found five more compensation records of executives who worked with Stephen Mullennix at UroGen Pharma Ltd. in 2020.
2020
Elizabeth Barrett
UroGen Pharma Ltd.
Chief Executive Officer
2020
Jason Smith
UroGen Pharma Ltd.
General Counsel
2020
Molly Henderson
UroGen Pharma Ltd.
Chief Financial Officer
2020
Peter Pfreundschuh
UroGen Pharma Ltd.
Chief Financial Officer
2020
Mark Schoenberg
UroGen Pharma Ltd.